Urea cycle disorders are inborn errors of metabolism from urea cycle disorders due to enzyme or transporter defects in ammonia removal. 

It is a genetic disorder caused due to dysfunctional urea cycle. It causes ammonia buildup and is dangerous to the central nervous system. 

Newborns born with severe mutations in early urea cycle enzymes quickly become critically ill after birth. 

Mutations in the first four urea cycle enzymes can cause severe illness in newborns within 36 to 48 hours post-birth. Urea cycle removes excess nitrogen from the body. 

Key Components of the Urea Cycle are: 

Carbamoyl Phosphate Synthetase I  

Ornithine Transcarbamylase  

Argininosuccinate Synthetase 

Argininosuccinate Lyase  

Arginase I  

Approximately 1 in 35,000 live births estimated to have Urea Cycle Disorders. 

UCD show higher rates in males due to X-linked inheritance. Females may also be affected but often have milder symptoms. 

There is no significant ethnic or geographic predilection for UCDs. They are distributed worldwide across all populations. 

Early diagnosis crucial for UCDs to prevent fatal hyperammonemia and high mortality rates in newborns. 

Severe hyperammonemia survivors may have long-term developmental, intellectual, and motor issues. 

Deficiency in Carbamoyl Phosphate Synthetase I results in reduced carbamoyl phosphate production leads to high blood ammonia levels and toxicity. 

Ornithine Transcarbamylase Deficiency disrupts conversion of ornithine and carbamoyl phosphate to citrulline.  

Deficiency in argininosuccinate synthetase impairs arginosuccinate synthesis, occurs elevated citrulline and ammonia levels in blood. 

Arginase I Deficiency inhibits arginine breakdown to urea. Astrocyte swelling in neonatal brains from hyperammonemia causes edema. Swelling frequency and degree impact severity of CNS disorders. 

Causes of urea cycle disorders as: 

Autosomal Recessive Inheritance 

X-Linked Recessive Inheritance 

Residual Enzyme Activity 

Genotype-Phenotype Correlation 

Low enzyme activity causes severe hyperammonemia and poor prognosis. Higher activity leads to milder symptoms and better prognosis. 

Early onset severe symptoms in newborns can lead to neurological damage and mortality if untreated. 

Symptoms of the condition may show later in life, with a generally better prognosis but still serious if untreated. 

Hyperammonemia leads to brain damage and developmental issues but is preventable with management. 

Urea Cycle Disorders affect individuals across all age groups, from neonates to adults. 

Gastrointestinal Examination 

Cardiovascular Examination 

Respiratory Examination 

Neurological Examination 

Musculoskeletal Examination 

For Neonatal-Onset UCDs: 

Lethargy, poor feeding, vomiting, hypotonia, seizures, respiratory distress 

For Infantile-Onset UCDs: 

Failure to thrive, recurrent vomiting, developmental delays, irritability, hypotonia 

For Childhood-Onset UCDs: 

Behavioral changes, learning difficulties, recurrent vomiting, lethargy, confusion 

Patients should increase enzyme activity to promote ammonia detoxification pathways. 

Sodium phenylacetate and sodium benzoate administer intravenously to lower ammonia levels. 

Maintain calorie intake to prevent catabolism and protein breakdown. 

Bladder training involves scheduled voiding and gradually increasing the intervals between voids to improve bladder capacity. 

Continuous monitoring ammonia, acid-base, electrolytes, overall metabolic state for these may require intensive care support. 

Urology

Limit protein intake of patient based on needs and enzyme activity to reduce ammonia production in metabolism. 

Low-protein medical foods and formulas to prevent ammonia production. 

Properly store low-protein and medical foods to prevent spoilage. 

Minimize stress, eat regularly, and monitor ammonia levels to maintain safe health standards. 

Proper education and awareness about urea cycle should be provided and its related causes with management strategies. 

Appointments with a urologist and preventing recurrence of disorder is an ongoing life-long effort. 

Urology

Sodium Phenylbutyrate: 

It converts ammonia to phenylacetylglutamine, which is excreted in the urine. 

Urology

Arginine: 

It supports the urea cycle to help in detoxification of ammonia. 

Urology

Dialysis is used in acute hyperammonemia cases when ammonia levels are extremely high and not able to be controlled with medications. 

Liver transplantation is suggested for patients with severe, recurrent hyperammonemia which is difficult to manage with medical therapy. 

Urology

In the initial diagnosis phase, evaluation of medical history and laboratory test to confirm diagnosis. 

Pharmacologic therapy is very effective in the treatment phase as it includes use of ammonia scavenger drugs and surgical intervention. 

In supportive care and management phase, patients should receive required attention such as lifestyle modification and rehabilitation. 

The regular follow-up visits with the urologist are schedule to check the improvement of patients along with treatment response.